MERCK (MERCK) News
Follow MERCK (MERCK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Merck earnings above expectations at 2.49 USD
Merck (MRK) released earnings per share at 2.49 USD, compared to market expectations of 2.28 USD.
EARNINGS | Oct 29, 2026, 10:36 AM UTC
L
Merck reports sustained tumor control with pimicotinib over two years
Merck says its Phase 3 study showed sustained tumor control with pimicotinib over two years.
EQUITY | Oct 26, 2026, 11:09 AM UTC
M
Merck Reports Pimicotinib Tumor Response at Two Years in Phase 3 TGCT Study
Merck reported a tumor response at two years in its phase 3 study of pimicotinib for TGCT.
EQUITY | Oct 26, 2026, 11:09 AM UTC
M
DAX closes up 0.53% at 26,440
The DAX Index rose 141 points, or 0.53%, on Friday to close at 26,440 points, with gains led by Scout24, Rheinmetall and SAP, while E.ON, Merck and Vonovia lagged.
EQUITY | Aug 14, 2026, 04:11 PM UTC
L
Merck Q2 2026 Earnings
Merck Q2 2026 Earnings
EARNINGS | Jul 30, 2026, 04:52 PM UTC